On October 2, 2023, Trisalus Life Sciences Entered Into A Standby Equity Purchase Agreement With Ya Ii Pn, Ltd.
Portfolio Pulse from Charles Gross
TriSalus Life Sciences, Inc. has entered into a Standby Equity Purchase Agreement with YA II PN, Ltd. (Yorkville), a fund managed by Yorkville Advisors Global, LP. The agreement allows TriSalus to sell up to $30,000,000 of common stock to Yorkville at any time during a 24-month period starting from October 2, 2023.
October 03, 2023 | 10:11 am
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
The agreement provides TriSalus with a potential source of funding by selling up to $30,000,000 of common stock to Yorkville. This could impact the company's stock price depending on how and when the option is exercised.
The agreement provides TriSalus with a potential source of funding, which could be positive for the company's financial stability. However, the sale of common stock could dilute existing shares, potentially leading to a decrease in share price. The impact on the stock price will depend on how and when the option to sell stock is exercised.
CONFIDENCE 85
IMPORTANCE 75
RELEVANCE 100